Search Results for "Hypertrophic Planus"

14:54 EDT 24th June 2017 | BioPortfolio

Matching Channels

Lichen Planus

Hypertrophic Cardiomyopathy

Ventricular Fibrillation VF

Ventricular fibrillation produces uncoordinated quivering of the ventricle with no useful contractions. It causes immediate syncope and death within minutes. Treatment is with cardiopulmonary resusc...

Matching News

Recreational Exercise in Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, defined as unexplained left ventricular hypertrophy, has an estimated prevalence of at least 1 in 500 and is among the most common forms of inherited heart disease. The pa...

Moderate exercise may benefit patients with hypertrophic cardiomyopathy

As one of the most common causes of sudden cardiac death in young people, a diagnosis of hypertrophic cardiomyopathy can push patients into sedentary lifestyles.

Brisk Walking Can Help in Hypertrophic Cardiomyopathy

The study "provides support for a regimen of unsupervised brisk walking 4 to 7 days per week for a minimum of 30 minutes, as a targeted intervention for patients with hypertrophic cardiom...

Moderate Exercise and Oxygen Consumption in Hypertrophic Cardiomyopathy

This randomized clinical trial assesses whether moderate-intensity exercise training, compared with usual activity, improves exercise capacity in adults with hypertrophic cardiomyopathy.

The myosin mesa and the basis of hypercontractility caused by hypertrophic cardiomyopathy mutations

A working model for β-cardiac myosin in the sequestered state and binding assays reveal interactions between the myosin head and tail that are disrupted by mutations associated with hypertrophic card...

Sirnaomics begins Phase IIa trial of STP705 to treat hypertrophic scar

Biopharmaceutical company Sirnaomics has initiated the Phase IIa trial of its small interfering RNA (siRNA) therapeutic candidate STP705 (Cotsiranib) to treat patients with hypertrophic scar.

Top 3 Emerging Trends Impacting the Global Hypertrophic Cardiomyopathy Therapeutics Market from 2017-2021: Technavio

Friday, April 21st 2017 at 3:43pm UTC LONDON–(BUSINESS WIRE)– Technavio’s latest report on the global hypertrophic cardiomyopathy therapeutics market provides an analysis of the most imp...

Attitudes, knowledge and consequences of uncertain genetic findings in hypertrophic cardiomyopathy

Matching PubMed Articles

Corneal Involvement by Lichen Planus Pigmentosus.

Lichen planus pigmentosus (LPP) is an exclusive form of lichen planus (LP) characterized by pigmentary incontinence in histopathologic slides.

TRPA1 may contribute to the exacerbation of oral lichen planus through Koebner phenomenon.

We would like to congratulate Kun et al. (Kun et al., 2016) for their recent publication entitled: "TRPA1 receptor is upregulated in human oral lichen planus". This article is very informative and e...

The efficacy of Aloe Vera in management of oral lichen planus: a systematic review and meta-analysis.

The main objective of oral lichen planus management is to control symptomatic outbreaks via eliminating lesions and alleviating symptoms. Corticosteroids; calcineurin inhibitors and most of the availa...

Review of Silicone Gel Sheeting and Silicone Gel for the Prevention of Hypertrophic Scars and Keloids.

Keloids and hypertrophic scars are fibroproliferative disorders of dermal tissue after skin injury. Many clinical control studies have reported evidence that silicone gel is effective in preventing an...

Lichen planus secondary to rabies vaccination.

Lichen planus (LP) is a papulosquamous disease withdistinctive clinical manifestations. The etiology of LPremains unknown. Recently, numerous cases of LPdeveloping after hepatitis B, influenza, and co...

Search Whole site using Google

Quick Search
Advertisement Advertisement